Hence, our findings offer new insights into the molecular mechanisms underlying COVID-19 and sepsis-induced ARDS and suggest CD3, CD247, CD2, CD40LG MMP-9, LCN2, and RETN as the potential targets for neutrophils in developing novel therapies and diagnostic tools for these diseases. This evidence concerns the gene LCN2 and Sepsis.